[(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H82NO10P — CID 156996564

IUPAC[(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
SMILESCC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCc1oc(CCCCC)c(C)c1C
InChIInChI=1S/C50H82NO10P/c1-8-10-12-13-22-28-33-45(52)34-29-23-18-16-14-15-17-19-25-31-37-49(53)57-41-46(42-59-62(55,56)58-40-39-51(5,6)7)60-50(54)38-32-26-21-20-24-30-36-48-44(4)43(3)47(61-48)35-27-11-9-2/h10,12,14-15,18-19,22-23,25,28-29,34,45-46,52H,8-9,11,13,16-17,20-21,24,26-27,30-33,35-42H2,1-7H3/b12-10-,15-14-,23-18-,25-19-,28-22-,34-29+/t45?,46-/m1/s1
InChIKeyDIWLFHBEQGOSLZ-SLHDRJLASA-N
MW888.18 g/mol
LogP11.01
Rot. Bonds37

About [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate (PubChem CID 156996564) has the molecular formula C50H82NO10P and a molecular weight of 888.18 g/mol. Its IUPAC name is [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate.

Molecular Properties

Compound Name[(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
PubChem CID156996564
Molecular FormulaC50H82NO10P
Molecular Weight888.18 g/mol
Exact Mass887.57
IUPAC Name[(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
SMILESCC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCc1oc(CCCCC)c(C)c1C
InChIInChI=1S/C50H82NO10P/c1-8-10-12-13-22-28-33-45(52)34-29-23-18-16-14-15-17-19-25-31-37-49(53)57-41-46(42-59-62(55,56)58-40-39-51(5,6)7)60-50(54)38-32-26-21-20-24-30-36-48-44(4)43(3)47(61-48)35-27-11-9-2/h10,12,14-15,18-19,22-23,25,28-29,34,45-46,52H,8-9,11,13,16-17,20-21,24,26-27,30-33,35-42H2,1-7H3/b12-10-,15-14-,23-18-,25-19-,28-22-,34-29+/t45?,46-/m1/s1
InChIKeyDIWLFHBEQGOSLZ-SLHDRJLASA-N
XLogP11.01
TPSA144.56 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds37
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500888.18
LogP ≤ 511.01
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate?
The IUPAC name of [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate (CID 156996564) is [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate.
What is the SMILES notation for [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate?
The canonical SMILES for [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate is CC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCc1oc(CCCCC)c(C)c1C.
What is the InChIKey of [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate?
The InChIKey is DIWLFHBEQGOSLZ-SLHDRJLASA-N. The full InChI is InChI=1S/C50H82NO10P/c1-8-10-12-13-22-28-33-45(52)34-29-23-18-16-14-15-17-19-25-31-37-49(53)57-41-46(42-59-62(55,56)58-40-39-51(5,6)7)60-50(54)38-32-26-21-20-24-30-36-48-44(4)43(3)47(61-48)35-27-11-9-2/h10,12,14-15,18-19,22-23,25,28-29,34,45-46,52H,8-9,11,13,16-17,20-21,24,26-27,30-33,35-42H2,1-7H3/b12-10-,15-14-,23-18-,25-19-,28-22-,34-29+/t45?,46-/m1/s1.
What are the key properties of [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate?
[(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate has a molecular weight of 888.18 g/mol, XLogP of 11.01, 37 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R)-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]-3-[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate is sourced from PubChem (CID 156996564), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).